A dual inhibitor of MMP-2 and MMP-9, known as SB-3CT, reduced brain lesion volumes and prevented neuronal loss and dendritic degeneration in an experimental mouse model of traumatic brain injury [57]. This evidence concerns the gene MMP2 and brain injury.